UK Biobank Revokes Access After Medical Data Appears on Alibaba
AI-generated from multiple sources. Verify before acting on this reporting.
LONDON — The UK Biobank charity revoked access to its medical database and paused new data approvals after health records from 500,000 volunteers were listed for sale on Alibaba, Chinese authorities confirmed Thursday. The incident marks a significant breach of data security protocols involving one of the world's largest biomedical research resources.
The data, which includes genetic information and health records, was downloaded by researchers under a legitimate contract before appearing on the Chinese e-commerce platform. UK Biobank stated it immediately suspended all current and future data access upon discovering the listing. The charity, based in London, manages the dataset used by scientists globally to study diseases and develop treatments.
Chinese authorities indicated that the data's appearance on Alibaba highlights vulnerabilities in approved access systems. Officials noted that large, diverse human genomic and health datasets are treated as strategic resources in China. The listing was removed after the breach was identified, though details regarding the specific researchers or institutions involved remain undisclosed.
Three research institutions participated in the project that led to the data download. UK Biobank has not specified which organizations were involved or how the data moved from the researchers to the online marketplace. The charity emphasized that all data access is governed by strict legal agreements requiring confidentiality and prohibiting unauthorized distribution.
The incident has raised concerns about international data security and the potential for sensitive health information to be exploited. UK Biobank's decision to pause new data access affects ongoing research projects worldwide. Scientists relying on the database for studies on cancer, heart disease, and other conditions face delays as the charity investigates the breach.
Chinese officials have not commented on whether the data was purchased or if the listing was part of a broader effort to acquire foreign genomic information. The situation underscores the tension between open scientific collaboration and the protection of sensitive personal data. UK Biobank is working with UK authorities to determine the full extent of the exposure.
Questions remain about how the data was transferred from the researchers to Alibaba and whether other datasets are at risk. The charity has not announced plans to notify the 500,000 volunteers whose information was involved. Researchers and privacy advocates are calling for stricter oversight of international data sharing agreements to prevent future incidents.